[ad_1]
FDA accepts Verastem NDA for priority review, stock jumps 20% (update)
[ad_2]
FDA accepts Verastem NDA for priority review, stock jumps 20% (update)
Posted by Posted by Posted by Posted by Posted by [ad_1]
FDA accepts Verastem NDA for priority review, stock jumps 20% (update)
[ad_2]